Nanjing Leads Biolabs Co.,Ltd

Nanning, Guangxi

OncologyantibodyPhase III

Compare Sign in to watch

What changed

Study registered, no phase assigned: CGM for Insulin-Treated T2DM During Post-Discharge Transition

3w agoTrial registeredJun 24, 2026Source filing (opens the source filing in a new tab)

Momentum

100no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase III

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

672 pre-ticker oncology companies at Phase III

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Grant
R35 · $358k · non-dilutive
Jun 1, 2026
UNIVERSITY OF CHICAGO · PI ZHOU, JIAN · NIGMS · award ends May 31, 2031 · Decoding the sequence basis of genome regulation
NIH RePORTER · NIH RePORTER 11337171 (opens the source filing in a new tab)
Trial
NA registered
May 11, 2026
Type 2 Diabetes Mellitus (T2DM) · RECRUITING · sponsor: Shanghai 6th People's Hospital · CGM for Insulin-Treated T2DM During Post-Discharge Transition
ClinicalTrials.gov · NCT07414277 (opens the source filing in a new tab)
Grant
R01 · $387k · non-dilutive
May 4, 2026
STATE UNIVERSITY OF NY,BINGHAMTON · PI ZHOU, JIAN · NIDCD · award ends Apr 30, 2031 · Velocity/Pressure Dual-Sensing Probe for Acoustic Measurements in the Human Ear Canal
NIH RePORTER · NIH RePORTER 11344060 (opens the source filing in a new tab)
Trial
NA registered
Jan 19, 2026
Critical Care, Acute Hypoxic Respiratory Failure, Ventilator-Induced Lung Injury · RECRUITING · sponsor: Capital Medical University · Inspiratory Effort-Targeted Pressure Support Ventilation (IT-PSV) Trial
ClinicalTrials.gov · NCT06526598 (opens the source filing in a new tab)
Trial
Study registered
Dec 18, 2025
Type 2 Diabetes, Glucose Metabolism Disorders · NOT_YET_RECRUITING · sponsor: Shanghai 6th People's Hospital · The CGM-OGTT Glycemic Homeostasis Study
ClinicalTrials.gov · NCT07288372 (opens the source filing in a new tab)
Trial
PHASE2 registered
Oct 20, 2025
Advanced Solid Tumour · RECRUITING · sponsor: Nanjing Leads Biolabs Co.,Ltd · A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]
ClinicalTrials.gov · NCT07111546 (opens the source filing in a new tab)
Trial
Study registered
Oct 9, 2025
Unresectable Hepatocellular Carcinom · NOT_YET_RECRUITING · sponsor: Shanghai Zhongshan Hospital · Conversion Therapy Using TACE/HAIC With Anti-Angiogenic and Immunotherapy for Initially Unresectable Hepatocellular Carcinoma Achieving Complete Response or Resectability, Followed by Surgery or Continued Systemic Treatment: A Prospective Cohort Study
ClinicalTrials.gov · NCT07206511 (opens the source filing in a new tab)
Grant
R01 · $2.2M · non-dilutive
Sep 10, 2025
UNIVERSITY OF WASHINGTON · PI MOSTAFAVI, SARA · NHGRI · award ends Aug 31, 2029 · Sequence-to-function models for mechanistic investigations of personal genomes
NIH RePORTER · NIH RePORTER 11129585 (opens the source filing in a new tab)
Trial
Study registered
Sep 1, 2025
Healthy Adult, Cushing Syndrome, Adrenal Insufficiency · RECRUITING · sponsor: Shanghai 6th People's Hospital · Establishment and Clinical Application of Reference Intervals of Salivary Cortisol
ClinicalTrials.gov · NCT07168122 (opens the source filing in a new tab)
Trial
Study registered
Sep 1, 2025
Hypercortisolism, Type 2 Diabetes (T2DM) · RECRUITING · sponsor: Shanghai 6th People's Hospital · Salivary Cortisol and Hypercortisolism in Type 2 Diabetes
ClinicalTrials.gov · NCT07156370 (opens the source filing in a new tab)
Trial
Study registered
Aug 30, 2025
Ventilator-Associated Pneumonia (VAP), Intensive Care Unit (ICU) Patients, Microbiome Dysbiosis · RECRUITING · sponsor: Jian-Xin Zhou · Pulmonary Microbiota Changes and Clinical Outcomes in Neurosurgical ICU Patients With Artificial Airways
ClinicalTrials.gov · NCT07129174 (opens the source filing in a new tab)
Trial
NA registered
May 20, 2025
Mechanical Ventilation, Critical Care, Inspiratory Effort · COMPLETED · sponsor: Jian-Xin Zhou · Use of Endotracheal Tube Cuff Pressure to Assess Inspiratory Effort During Pressure Support Ventilation
ClinicalTrials.gov · NCT06968793 (opens the source filing in a new tab)
Trial
NA registered
May 20, 2025
Critical Care, Inspiratory Effort · RECRUITING · sponsor: Jian-Xin Zhou · Use of Nasal Pressure to Assess Inspiratory Effort Under Different Oxygen Treatments
ClinicalTrials.gov · NCT06970990 (opens the source filing in a new tab)
Trial
NA registered
Mar 1, 2025
Critical Care, Oxygen Therapy, Mechanical Ventilation · RECRUITING · sponsor: Jian-Xin Zhou · Comparison of Physiological Effects of Two High-Flow Tracheal Oxygen Versus T-Piece During Spontaneous Breathing Trials
ClinicalTrials.gov · NCT06816706 (opens the source filing in a new tab)
Trial
NA registered
Feb 20, 2025
Critical Care, Oxygen Therapy, Tracheostomy · NOT_YET_RECRUITING · sponsor: Jian-Xin Zhou · Comparison of Physiological Effects of Two Types of High-Flow Oxygen Therapy in Tracheostomized Patients
ClinicalTrials.gov · NCT06816745 (opens the source filing in a new tab)
Trial
NA registered
Jan 20, 2025
Critical Care, Acute Hypoxic Respiratory Failure, Ventilator Lung · RECRUITING · sponsor: Capital Medical University · A Pilot Trial of Pressure Muscle Index-Targeted PSV Trial
ClinicalTrials.gov · NCT06769360 (opens the source filing in a new tab)
Trial
NA registered
Apr 18, 2024
Diabetes Mellitus · COMPLETED · sponsor: Shanghai 6th People's Hospital · Effect of Continuous Glucose Monitoring System Alerts on Diabetes Management in the Hospital
ClinicalTrials.gov · NCT05941286 (opens the source filing in a new tab)
Trial
NA registered
Aug 1, 2023
Mechanical Ventilation · RECRUITING · sponsor: Capital Medical University · PMI Guide PS Setting in Pressure Support-ventilated Patients
ClinicalTrials.gov · NCT05963737 (opens the source filing in a new tab)
Grant
DP2 · $685k · non-dilutive
Sep 23, 2021
UNIVERSITY OF CHICAGO · PI ZHOU, JIAN · NIGMS · award ends Aug 31, 2026 · Sequence models of genome regulatory architecture in 3D
NIH RePORTER · NIH RePORTER 11430672 (opens the source filing in a new tab)
Trial
PHASE2/PHASE3 registered
Mar 25, 2021
Hepatocellular Carcinoma, Immunotherapy, Molecular Targeted Therapy · ACTIVE_NOT_RECRUITING · sponsor: Shanghai Zhongshan Hospital · Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma
ClinicalTrials.gov · NCT04521153 (opens the source filing in a new tab)
Trial
PHASE2 registered
Aug 1, 2020
Intrahepatic Cholangiocarcinoma · ACTIVE_NOT_RECRUITING · sponsor: Shanghai Zhongshan Hospital · PD-1 Antibody (SHR-1210) Plus Capecitabine in Patients with Intrahepatic Cholangiocarcinoma After Surgery
ClinicalTrials.gov · NCT04295317 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 79%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Investigators

The principal investigators named on the grants below. Each links to their federal grant record and every other company traced to their work.

Event stream

Every scored event, newest first. This is what momentum is computed from.

Study registered, no phase assigned: CGM for Insulin-Treated T2DM During Post-Discharge Transition
3w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: CGM for Insulin-Treated T2DM During Post-Discharge Transition
3w agoTrial recruitingSource (opens the source filing in a new tab)
Phase II trial registered: A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]
7w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]
7w agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: Pulmonary Microbiota Changes and Clinical Outcomes in Neurosurgical ICU Patients With Artificial Airways
8w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Pulmonary Microbiota Changes and Clinical Outcomes in Neurosurgical ICU Patients With Artificial Airways
8w agoTrial recruitingSource (opens the source filing in a new tab)
NIH R35 · $0.4M · Decoding the sequence basis of genome regulation
2mo agoNew grantSource (opens the source filing in a new tab)
NIH R01 · $0.4M · Velocity/Pressure Dual-Sensing Probe for Acoustic Measurements in the Human Ear Canal
2mo agoNew grantSource (opens the source filing in a new tab)
Study registered, no phase assigned: Use of Endotracheal Tube Cuff Pressure to Assess Inspiratory Effort During Pressure Support Ventilation
6mo agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: Use of Endotracheal Tube Cuff Pressure to Assess Inspiratory Effort During Pressure Support Ventilation
6mo agoTrial completedSource (opens the source filing in a new tab)
Study registered, no phase assigned: Inspiratory Effort-Targeted Pressure Support Ventilation (IT-PSV) Trial
6mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Inspiratory Effort-Targeted Pressure Support Ventilation (IT-PSV) Trial
6mo agoTrial recruitingSource (opens the source filing in a new tab)
NIH DP2 · $0.7M · Sequence models of genome regulatory architecture in 3D
6mo agoGrant renewalSource (opens the source filing in a new tab)
Study registered, no phase assigned: Effect of Continuous Glucose Monitoring System Alerts on Diabetes Management in the Hospital
6mo agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: Effect of Continuous Glucose Monitoring System Alerts on Diabetes Management in the Hospital
6mo agoTrial completedSource (opens the source filing in a new tab)
Study registered, no phase assigned: The CGM-OGTT Glycemic Homeostasis Study
6mo agoTrial registeredSource (opens the source filing in a new tab)
Study registered, no phase assigned: Conversion Therapy Using TACE/HAIC With Anti-Angiogenic and Immunotherapy for Initially Unresectable Hepatocellular Carcinoma Achieving Complete Response or Resectability, Followed by Surgery or Continued Systemic Treatment: A Prospective Cohort Study
9mo agoTrial registeredSource (opens the source filing in a new tab)
Study registered, no phase assigned: Establishment and Clinical Application of Reference Intervals of Salivary Cortisol
10mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Establishment and Clinical Application of Reference Intervals of Salivary Cortisol
10mo agoTrial recruitingSource (opens the source filing in a new tab)
NIH R01 · $2.2M · Sequence-to-function models for mechanistic investigations of personal genomes
10mo agoNew grantSource (opens the source filing in a new tab)
Study registered, no phase assigned: Salivary Cortisol and Hypercortisolism in Type 2 Diabetes
10mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Salivary Cortisol and Hypercortisolism in Type 2 Diabetes
10mo agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: Use of Nasal Pressure to Assess Inspiratory Effort Under Different Oxygen Treatments
May 2025Trial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Use of Nasal Pressure to Assess Inspiratory Effort Under Different Oxygen Treatments
May 2025Trial recruitingSource (opens the source filing in a new tab)
Phase III trial registered: Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma
May 2025Trial registeredSource (opens the source filing in a new tab)
Study registered, no phase assigned: Comparison of Physiological Effects of Two High-Flow Tracheal Oxygen Versus T-Piece During Spontaneous Breathing Trials
Mar 2025Trial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Comparison of Physiological Effects of Two High-Flow Tracheal Oxygen Versus T-Piece During Spontaneous Breathing Trials
Mar 2025Trial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: Comparison of Physiological Effects of Two Types of High-Flow Oxygen Therapy in Tracheostomized Patients
Feb 2025Trial registeredSource (opens the source filing in a new tab)
Study registered, no phase assigned: A Pilot Trial of Pressure Muscle Index-Targeted PSV Trial
Feb 2025Trial registeredSource (opens the source filing in a new tab)
Trial now recruiting: A Pilot Trial of Pressure Muscle Index-Targeted PSV Trial
Feb 2025Trial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: PMI Guide PS Setting in Pressure Support-ventilated Patients
Jan 2025Trial registeredSource (opens the source filing in a new tab)
Trial now recruiting: PMI Guide PS Setting in Pressure Support-ventilated Patients
Jan 2025Trial recruitingSource (opens the source filing in a new tab)
Phase II trial registered: PD-1 Antibody (SHR-1210) Plus Capecitabine in Patients with Intrahepatic Cholangiocarcinoma After Surgery
Jan 2025Trial registeredSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Peer position

Grant to raise

R35 · $358k · non-dilutive

NA registered

R01 · $387k · non-dilutive

NA registered

Study registered

PHASE2 registered

Study registered

R01 · $2.2M · non-dilutive

Study registered

Study registered

Study registered

NA registered

NA registered

NA registered

NA registered

NA registered

NA registered

NA registered

DP2 · $685k · non-dilutive

PHASE2/PHASE3 registered

PHASE2 registered